Aspirin for Breast Cancer

"Aspirin has a variety of uses, such as reducing inflammation, managing pain, and preventing blood clotting during dental procedures and pci."

"Aspirin is a Phase 3 trial drug, which means that while there is some data supporting efficacy, there are multiple rounds of data supporting safety. Therefore, our team at Power has estimated the safety of Aspirin to be a 3."

"Unfortunately, this particular study is not presently looking for patients to participate. The trial was initially posted on December 8th, 2016 and was last updated January 6th, 2022. There are, however, 2,538 other trials that are recruiting patients."

"Aspirin clinical trials began in 2002 with Sanofi as the primary sponsor. The first Phase 3 trial had 413 participants and aspirin was approved for general use after this point. As of now, there are 181 active aspirin studies being conducted in 61 countries and 1451 cities."

"Those with malignant neoplasms who are also within the ages of 18 and 69 may qualify for this clinical trial. Currently, the study is looking for 3021 individuals."

"In order to be eligible for this trial, applicants must fall between the ages of 18 to 69. For context, there are 80 different trials underway for treatments targeting those under 18 and 2441 for those over the age of 65."

"There are 100 sites where this clinical trial is offered, such as University of Kansas Cancer Center - North in Kansas City, Lowell General Hospital in Lowell, and Saint Francis Regional Medical Center in Shakopee."

"In 2002, at Institut Curie Hopital, aspirin was first studied. Since that time, there have been 18,677 completed clinical trials. As of now, there are 181 active medical studies, a majority of which are based in Kansas City, Missouri."

"Unfortunately, this trial is not recruiting at this moment. However, there are 2357 trials for patients with malignant neoplasms and 181 studies for patients taking Aspirin."